Proteome-wide survey of the autoimmune target repertoire in autoimmune polyendocrine syndrome type 1Show others and affiliations
2016 (English)In: Scientific Reports, E-ISSN 2045-2322, Vol. 6, article id 20104Article in journal (Refereed) Published
Abstract [en]
Autoimmune polyendocrine syndrome type 1 (APS1) is a monogenic disorder that features multiple autoimmune disease manifestations. It is caused by mutations in the Autoimmune regulator (AIRE) gene, which promote thymic display of thousands of peripheral tissue antigens in a process critical for establishing central immune tolerance. We here used proteome arrays to perform a comprehensive study of autoimmune targets in APS1. Interrogation of established autoantigens revealed highly reliable detection of autoantibodies, and by exploring the full panel of more than 9000 proteins we further identified MAGEB2 and PDILT as novel major autoantigens in APS1. Our proteome-wide assessment revealed a marked enrichment for tissue-specific immune targets, mirroring AIRE's selectiveness for this category of genes. Our findings also suggest that only a very limited portion of the proteome becomes targeted by the immune system in APS1, which contrasts the broad defect of thymic presentation associated with AIRE-deficiency and raises novel questions what other factors are needed for break of tolerance.
Place, publisher, year, edition, pages
Springer Nature, 2016. Vol. 6, article id 20104
National Category
Endocrinology and Diabetes
Identifiers
URN: urn:nbn:se:oru:diva-110274DOI: 10.1038/srep20104ISI: 000368996700001PubMedID: 26830021Scopus ID: 2-s2.0-84957560723OAI: oai:DiVA.org:oru-110274DiVA, id: diva2:1819915
Funder
Swedish Research CouncilSwedish Research Council FormasRagnar Söderbergs stiftelseTorsten Söderbergs stiftelseNovo Nordisk FoundationNIH (National Institutes of Health)
Note
Funding Agencies:
Swedish Research Council
Formas Research Council
Torsten and Ragnar SöderbergsFoundations
Novonordisk Foundation and the Intramural Research Program
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institutes of Health, Bethesda, Maryland,USA
2023-12-152023-12-152023-12-20Bibliographically approved